Prescription drug · NDA
Dopamine Hydrochloride and Dextrose NDC 0338-1009
dopamine hydrochloride · Dopamine hydrochloride 320 mg/100mL · Injection, Solution · Intravenous · Baxter Healthcare Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0338-1009-02 | 00338100902 | 18 BAG in 1 CARTON (0338-1009-02) / 250 mL in 1 BAGMarketed from Mar 27, 1987 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dopamine Hydrochloride and Dextrose
- Generic name (nonproprietary)
- dopamine hydrochloride
- Active ingredients
- Dopamine hydrochloride — 320 mg/100mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019615
- Marketing start
- Listing expires
- Other FDA classes
- Catecholamines (Chemical structure)
- Identifiers
- Product ID 0338-1009_edc9a091-4cb5-4ec7-b6f9-44d2d588bab9SPL ID edc9a091-4cb5-4ec7-b6f9-44d2d588bab9SPL set ID cb97d4a0-89ed-407c-a763-209386b6f75cRxCUI 1292887, 1743869, 1743871, 1743877, 1743879UNII 7L3E358N9L
- Pharmacologic class
- Catecholamine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400338100902followed by a unit qualifier and the quantityPackage 00338-1009-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Dopamine hydrochloride is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarctions, trauma, endotoxic septicemia, open heart surgery, renal failure and chronic cardiac decompensation as in congestive failure. Where appropriate, restoration of blood volume with a suitable plasma expander or whole blood should be instituted or completed prior to administration of dopamine hydrochloride. Patients most likely to respond adequately to dopamine hydrochloride are those in whom physiological parameters, such as urine flow, myocardial function and blood pressure have not undergone profound deterioration. Reports indicate …
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 019615
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dopamine Hydrochloride and Dextrosedopamine hydrochloride | Dopamine hydrochloride 80 mg/100mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-1005 |
| Dopamine Hydrochloride and Dextrosedopamine hydrochloride | Dopamine hydrochloride 160 mg/100mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-1007 |
| Dopamine Hydrochloride and Dextrosedopamine hydrochloride | Dopamine hydrochloride 160 mg/100mL | Injection, SolutionIntravenous | ProPharma Distribution | 84549-007 |